Skip to main content
. 2020 Jan 13;2020(1):CD012643. doi: 10.1002/14651858.CD012643.pub3

Abramson 2010.

Notes Title: End of treatment but not interim PET scan predicts outcome in non‐bulky limited stage Hodgkin lymphoma. (Conference abstract)
Aim

  • To establish the prognostic value of interim PET scans in limited stage patients with non‐bulky disease


Study design

  • Retrospective


Country/treatment centre(s)

  • USA (Massachusetts General Hospital, Dana‐Farber Cancer Institute, Harvard School of Public Health, Boston MA)


Number of included participants

  • 96


Inclusion criteria

  • Non‐bulky limited stage cHL treated at the institutions between 2000 and 2008; Bulk was defined as a mass >=10 cm or >=1/3 of the intrathoracic diameter.


Exclusion criteria

  • None


Treatment

  • 4 to 6 cycles of ABVD with or without IFRT


Primary outcome measure(s)

  • Overall survival

  • Progression‐free survival